XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies (Tables)
9 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of share purchase warrants outstanding
          
Number  Exercise Price  Expiry Date
 150,000   $3.17   May 6, 2024
 10,000   $12.00   April 21, 2026
 160,000         
Schedule of outstanding stock purchase options
                     
         Weighted Average   
      Weighted Average  Grant Date Fair  Aggregate intrinsic
      Exercise Price  Value  Value
   Number of Options  ($)  ($)  ($)
Outstanding, September 30, 2021    11,330,903    5.74        140,132,451 
Granted    2,358,000    10.13    7.07     
Forfeited    (118,750)   6.56    5.23     
Exercised    (400,537)   2.52    1.88    4,201,015 
Outstanding, September 30, 2022    13,169,616    6.61         62,267,309 
Granted    1,914,000    9.33    6.62     
Exercised    (234,753)   3.87    2.91    1,297,062 
Forfeited    (150,000)   12.69    5.64     
Outstanding, June 30, 2023    14,698,863    6.95         39,065,774 
Exercisable, June 30, 2023    10,027,446    4.91         38,730,916 
Schedule Of Share-based Payment Arrangement, Option, Activity
                                
         Weighted average         
      Number of  remaining  Weighted  Number of  Weighted
Range of exercises prices  outstanding  contractual life  average  vested  average
From  To  options  (in years)  exercise price  options  exercise price
$0.92   $3.00    3,800,309    4.34   $2.29    3,800,309   $2.29 
$3.01   $5.00    2,022,500    4.57   $3.28    2,022,500   $3.28 
$5.01   $9.00    5,250,054    6.46   $6.91    3,287,887   $6.09 
$9.01   $13.00    2,054,000    8.64   $10.62    432,167   $11.47 
$13.01   $25.00    1,572,000    7.74   $18.29    484,583   $18.50 
           14,698,863    6.09   $6.95    10,027,446   $4.91 
Schedule of general and administrative expenses and research and development expenses
                    
   Three months ended June 30,  Nine months ended June 30,
   2023  2022  2023  2022
General and administrative  $1,451,471   $1,490,267   $4,450,841   $4,739,021 
Research and development   2,415,310    2,498,347    8,732,512    7,597,823 
Total stock-based compensation  $3,866,781   $3,988,614   $13,183,353   $12,336,844 
Schedule of weighted average assumptions for fair value of each option award
          
   2023  2022
Risk-free interest rate   3.69%   3.10%
Expected life of options (years)   5.63    5.51 
Annualized volatility   85.16%   84.12%
Dividend rate   0.00%   0.00%